CRT-0044876 | m-entrepreneurship.com

Product Name :
CRT-0044876

Search keywords :
APE1

drugId :
null

Target Vo:
DNA-(apurinic or apyrimidinic site) lyase

Target Vo Short Name :
DNA-(apurinic or apyrimidinic site) lyase

Moa_Name:
DNA-(apurinic or apyrimidinic site) lyase inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Cancer Research UK

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Neoplasms

Termination Status :
Preclinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
RIP Rabbit mAb Purity & Documentation
EIF2A Rabbit mAb manufacturer
CLDN1 Antibody: CLDN1 Antibody is an unconjugated, approximately 23 kDa, rabbit-derived, anti-CLDN1 polyclonal antibody. CLDN1 Antibody can be used for: WB, ELISA, IHC-, IHC-, IF expriments in human, mouse, and predicted: rat, pig, cow, horse, rabbit, sheep, guinea pig background without labeling.

Author: Betaine hydrochloride

Related Posts